European Commission clears extended licence to JanssenZytiga

Janssen-Cilag International NV (Janssen) has announced European Commission approval of an extended licence to the oral, once-daily medication Zytiga (abiraterone acetate).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news